The exceptional strength of the UK's life science base has translated to a world leading position in drug development. We can help with all aspects of the drug discovery pipeline, from target identification by high throughput methodologies, to organic synthesis of small molecules coupled with structural and functional studies to inform QSAR through to formulation science and investigations of efficiency of tabletting, disintegration and dissolution.
Whether you are an emerging biotech company or a large player in the pharmaceutical industry, JBL Science can partner you in the various stages of the pipeline towards discovery of the next medicines. Our bioscience laboratories allow us to work with cellular models of disease and we routinely study tissue samples to investigate disease mechanisms to define putative drug targets. Our proteomic and metabolomic workflows facilitate biomarker discovery to allow surrogates of disease course to be measured quantitatively.
We can access significant power in organic synthesis, which we integrate seamlessly with structural and functional studies, underpinned by computational simulations. Our mass spectrometry experts are skilled in method development to support ADME studies and the team of experts at our disposal allows us to work on all aspects of the drug development process up to clinical studies.
Put our medicinal chemists to the test - contact us today
Key application areas of relevance to the pharmaceutical industry
Molecular structure determination
Tools and technologies of relevance include
High Performance Liquid Chromatography
Ultra Performance Liquid Chromatography
Liquid Chromatography-Tandem Mass Spectrometry
High Resolution Mass Spectrometry
Proteomic and Metabolomic Pipelines